NCT01839760已完成不适用
Prospective Study to Evaluate Viral Shedding Patterns and Clinical Outcomes of Hospitalized Adult Influenza Patients
Crucell Holland BV5 个研究点 分布在 3 个国家目标入组 150 人开始时间: 2012年12月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
- 试验地点
- 5
- 主要终点
- Viral load/Viral shedding
研究概览
简要总结
The objective of the study is virological assessment (e.g., proportion of prolonged viral shedding, median days to viral clearance, and viral load) in laboratory-confirmed adult influenza patients admitted to the general ward and/or to the ICU and to assess the correlation with the clinical manifestations and prognosis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Written informed consent
- •Hospitalized or admitted to ICU for influenza
- •Age ≥18 years
- •Laboratory confirmation of influenza A or B
排除标准
- •Informed consent not given
结局指标
主要结局
Viral load/Viral shedding
时间窗: Day 15
Outcome is the decay rate in viral load during hospital stay measured by quantitative polymerase chain reaction (QPCR)
次要结局
未报告次要终点
研究者
研究点 (5)
Loading locations...
相似试验
已完成
不适用
Assessement of Viral Shedding Duration After a Respiratory Tract Infection in Oncology and Hematology PatientsRespiratory Tract Viral InfectionNCT03389997Poitiers University Hospital44
已完成
不适用
Viral Clearance and Epidemiological Characteristics in Patients With MonkeypoxMonkeypoxNCT05476744Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia77
已完成
不适用
A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric ParticipantsRSV InfectionsNCT06746051Shionogi100
已完成
2 期
A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 StudiesHCV InfectionNCT00726882AbbVie (prior sponsor, Abbott)35
撤回
2 期
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza InfectionInfluenzaNCT01992276Crucell Holland BV